2026-2030 ESG Objectives
After analyzing the regulatory framework introduced by the CSRD, the identification and assessment of key ESG risks and opportunities have guided the definition of Diasorin’s 2026–2030 ESG Plan.
The Plan represents the reference framework for the implementation and management of the Group’s ESG priorities, enabling structured monitoring of progress over time across environmental, social, and governance dimensions.
It is designed to coordinate and align the organization towards shared objectives, while strengthening the Group’s positive impact in the social and environmental areas while reinforcing its ongoing commitment to transparency, integrity, and accountability.
ESG Plan 2026 – 2030
Improve Group’s energy efficiency
KPIs: -600 tons of CO₂ in industrial sites.
timeline
2030
Strengthen Diversity & Inclusion
KPIs: 100% of employees trained on D&I.
timeline
2030
Enhance employee wellbeing
KPIs: ≥80% of Group employees covered by employee assistance programs.
timeline
2030
Promote scientific culture in high schools
KPIs: 5 €/mln investment over 2026-2030 to Fondazione Diasorin.
timeline
2030
Support women’s health and autoimmune diseases diagnosis
KPIs: > 20 high clinical value assays validated by 2030.
timeline
2030
Strengthen ESG governance
KPIs: ESG-linked remuneration targets for strategic executives.
timeline